A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With Solid Tumors
Clinical trial NCT07262164 · RECRUITING
Trial details
- NCT number
- NCT07262164
- Sponsor
- Shanghai Virogin Biotech Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-18
- Primary completion
- 2027-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.